Form 4 Tracker
Darren Sherman

Director, President and Chief Operating Officer · 10 filings · Latest: Oct 1, 2026

Orchestra BioMed Holdings, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
OBIO
Darren ShermanDirector, President and Chief Operating OfficerOct 1, 2026
Sale
$6.3615,000$95.4K1,119,402
OBIO
Sherman Darren—Oct 1, 2026
Proposed Sale
$6.2715,000$94.0K—
OBIO
Darren ShermanDirector, President and Chief Operating OfficerSep 1, 2026
Sale
$4.9415,000$74.1K1,134,402
OBIO
Sherman Darren—Sep 1, 2026
Proposed Sale
$5.0215,000$75.3K—
OBIO
Darren ShermanDirector, President and Chief Operating OfficerAug 26, 2026
Purchase
$5.332,000$10.7K2,000
OBIO
Darren ShermanDirector, President and Chief Operating OfficerAug 3, 2026
Sale
$4.0915,000$61.4K1,154,327
OBIO
Sherman Darren—Aug 3, 2026
Proposed Sale
$4.0915,000$61.3K—
OBIO
Darren ShermanDirector, President and Chief Operating OfficerJul 1, 2026
Sale
$4.2715,000$64.0K1,169,327
OBIO
Sherman Darren—Jul 1, 2026
Proposed Sale
$4.3215,000$64.8K—
OBIO
Darren ShermanDirector, President and Chief Operating OfficerJun 1, 2026
Sale
$3.8715,000$58.0K1,184,327
OBIO
Sherman Darren—Jun 1, 2026
Proposed Sale
$3.8715,000$58.0K—
OBIO
Sherman Darren—Sep 10, 2024
Proposed Sale
$5.316,904$36.6K—
OBIO
Sherman Darren—Sep 9, 2024
Proposed Sale
$5.486,804$37.3K—
OBIO
Sherman Darren—Sep 6, 2024
Proposed Sale
$5.656,819$38.5K—
OBIO
Sherman Darren—Sep 5, 2024
Proposed Sale
$5.856,961$40.7K—
OBIO
Sherman Darren—Sep 4, 2024
Proposed Sale
$6.106,837$41.7K—